Clarithromycin (Biaxin)- Potential Increased Risk of Heart Problems or Death in Patients
FDA is advising caution before prescribing the antibiotic clarithromycin (Biaxin) to patients with heart disease because of a potential increased risk of heart problems or death that can occur years later. FDAs recommendation is based on a review of the results of a 10-year